CAS 112835-48-0
:1-Naphthalenol,5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-,(6R)-
Description:
1-Naphthalenol, 5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-, (6R)-, with the CAS number 112835-48-0, is a complex organic compound characterized by its naphthalene core structure, which is a fused bicyclic aromatic hydrocarbon. The presence of a hydroxyl group (-OH) at the 1-position of the naphthalene ring contributes to its classification as an alcohol. The compound features a tetrahydro configuration, indicating that it has undergone partial hydrogenation, resulting in a saturated structure that enhances its solubility in various solvents. The propyl and thienyl substituents introduce additional functional groups that can influence its biological activity and chemical reactivity. This compound may exhibit specific pharmacological properties due to its unique structural features, making it of interest in medicinal chemistry. Its stereochemistry, indicated by the (6R) designation, suggests that it has a specific three-dimensional arrangement that could affect its interactions with biological targets. Overall, this compound's characteristics make it a subject of interest for further research in both synthetic and medicinal chemistry.
Formula:C19H25NOS
InChI:InChI=1S/C19H25NOS/c1-2-11-20(12-10-17-6-4-13-22-17)16-8-9-18-15(14-16)5-3-7-19(18)21/h3-7,13,16,21H,2,8-12,14H2,1H3/t16-/m1/s1
InChI key:KFQYTPMOWPVWEJ-MRXNPFEDSA-N
SMILES:CCCN(CCC1=CC=CS1)[C@@H]2CCC3=C(C2)C=CC=C3O
Synonyms:- 1-Naphthalenol,5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-,(R)-
- (+)-N 0437
- N 0924
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
(R)-6-(Propyl(2-(thiophen-2-yl)ethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-ol
CAS:(R)-6-(Propyl(2-(thiophen-2-yl)ethyl)amino)-5,6,7,8-tetrahydronaphthalen-1-olPurity:98%Molecular weight:315.480011ent-Rotigotine
CAS:Applications It is a non-ergot dopamine agonist drug and is indicated for the treatment of Parkinson’s disease.
References Loschmann, P., et al.: Eur. J. Pharmacol., 166, 373 (1989), Edgar, D., et al.: J. Pharmacol. Exp. Ther., 283, 757 (1997), Ferreira, J., et al.: Lancet, 355, 1333 (2000), Arnulf, I., et al.: Neurology, 58, 1019 (2002), Wisor, J., et al.: Neuroscience, 132, 1027 (2005),Formula:C19H25NOSColor and Shape:NeatMolecular weight:315.47




